TY - JOUR
T1 - Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND
T2 - Sentinel node vs Observation after axillary UltraSouND)
AU - Gentilini, Oreste
AU - Veronesi, Umberto
PY - 2012/10
Y1 - 2012/10
N2 - Sentinel lymph node biopsy (SLNB) is the standard approach for axillary staging in patients with early breast cancer. Recent data showed no outcome difference in patients with positive sentinel node between axillary dissection vs no further axillary surgery, raising doubts on the role of SLNB itself. Therefore, a new trial was designed comparing SLNB vs observation when axillary ultra-sound is negative in patients with small breast cancer candidates to breast conserving surgery.
AB - Sentinel lymph node biopsy (SLNB) is the standard approach for axillary staging in patients with early breast cancer. Recent data showed no outcome difference in patients with positive sentinel node between axillary dissection vs no further axillary surgery, raising doubts on the role of SLNB itself. Therefore, a new trial was designed comparing SLNB vs observation when axillary ultra-sound is negative in patients with small breast cancer candidates to breast conserving surgery.
KW - Axillary surgery
KW - Breast cancer treatment
KW - Sentinel lymph node biopsy (SLNB)
KW - Ultra-sound
UR - http://www.scopus.com/inward/record.url?scp=84865977722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865977722&partnerID=8YFLogxK
U2 - 10.1016/j.breast.2012.06.013
DO - 10.1016/j.breast.2012.06.013
M3 - Article
C2 - 22835916
AN - SCOPUS:84865977722
VL - 21
SP - 678
EP - 681
JO - Breast
JF - Breast
SN - 0960-9776
IS - 5
ER -